Klaus Braun

Title: Klaus Braun: Innovator in Ergoline Derivatives

Introduction

Klaus Braun is a notable inventor based in Radebeul, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the production of ergoline derivatives. With a total of 2 patents, his work has implications for both medicinal chemistry and pharmacology.

Latest Patents

Klaus Braun's latest patents include a process for the fermentation production of ergoline derivatives. This innovative method involves forming a submerged culture under aerobic conditions by inoculating an aqueous medium with a carbon source, nitrogen source, and nutrient salts. The inoculum consists of spores obtained from a strain of Claviceps purpurea, which is then cultivated to extract the formed alkaloids. Additionally, he has developed novel 21-deoxydihydroajmaline derivatives characterized by their antiarrhythmic activity. These derivatives have specific structural formulas that enhance their therapeutic potential.

Career Highlights

Klaus Braun is associated with Veb Arzneimittelwerk Dresden, where he has been instrumental in advancing pharmaceutical research. His expertise in fermentation processes and alkaloid chemistry has positioned him as a key figure in the development of new medicinal compounds.

Collaborations

Throughout his career, Klaus has collaborated with notable colleagues, including Eva Borowski and Klaus Breuel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Klaus Braun's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to impact the development of important medicinal compounds.